David Festus Charles Moffat

David Festus Charles Moffat

Private Equity Investor chez
General Inception
Health Technology
Consumer Services
Finance

Profil

David Festus Charles Moffat was the founder of Macrophage Pharma Ltd. which was founded in 2014, where he held the title of Chief Technology Officer from 2020 to 2022.
Currently, he is the VP Chemistry at General Inception Management LLC since 2022.
Previously, he was the Head-Chemistry at Celltech Group Plc and Chroma Therapeutics Ltd. from 2004 to 2012.
Dr. Moffat received his undergraduate and doctorate degrees from the University of Glasgow.

Postes actifs de David Festus Charles Moffat

SociétésPosteDébut
Private Equity Investor 01/09/2022

Anciens postes connus de David Festus Charles Moffat

SociétésPosteFin
Fondateur 01/04/2022
Corporate Officer/Principal 01/01/2012
Corporate Officer/Principal -
Voir l'expérience en détail de David Festus Charles Moffat

Formation de David Festus Charles Moffat

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

9

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées5

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. David Festus Charles Moffat
🔇